Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 3,000 shares, an increase of 25.0% from the February 13th total of 2,400 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 30.0 days. Currently, 0.0% of the company's stock are short sold.
Sartorius Aktiengesellschaft Stock Performance
SARTF stock traded up $3.31 during trading hours on Friday, reaching $199.31. The stock had a trading volume of 1 shares, compared to its average volume of 95. The company has a debt-to-equity ratio of 1.17, a current ratio of 2.02 and a quick ratio of 1.13. The stock has a market capitalization of $6.82 billion, a PE ratio of 151.00 and a beta of 1.11. The stock has a 50-day simple moving average of $210.10 and a 200 day simple moving average of $202.88. Sartorius Aktiengesellschaft has a fifty-two week low of $175.93 and a fifty-two week high of $290.00.
Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last announced its quarterly earnings data on Monday, February 17th. The company reported $1.11 EPS for the quarter. The business had revenue of $967.37 million during the quarter. Sartorius Aktiengesellschaft had a return on equity of 7.33% and a net margin of 2.48%.
Analyst Upgrades and Downgrades
Separately, Guggenheim upgraded shares of Sartorius Aktiengesellschaft to a "strong-buy" rating in a research note on Thursday, December 19th.
Read Our Latest Analysis on Sartorius Aktiengesellschaft
About Sartorius Aktiengesellschaft
(
Get Free Report)
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
See Also
Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.
While Sartorius Aktiengesellschaft currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
